Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.

The US struck a framework trade agreement with the European Union on Sunday (July 27), imposing a 15 per cent import tariff ...

The U.S. struck a framework trade agreement with the European Union on Sunday, imposing a 15% import tariff on most EU goods ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

Global pharmaceutical giants make billions of dollars in Australia but pay a fraction of that in tax. They say the price they ...

European Commission president said 15 per cent was the "best we could get". Read more at straitstimes.com. Read more at ...

Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

The council describes itself as a "national, non-partisan not-for-profit with members from both government & the private sector, and says that "virtually all major players involved in public ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...